The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_206933.3(USH2A):c.7167C>T (p.Ser2389=)

CA1394924

681822 (ClinVar)

Gene: USH2A (HGNC:7399)
Condition: Usher syndrome (MONDO:0019501)
Inheritance Mode: Autosomal recessive inheritance
UUID: 0f97b706-2a00-4fce-8bbe-6744fe0a63bc
Approved on: 2020-05-26
Published on: 2020-05-26

HGVS expressions

NM_206933.3(USH2A):c.7167C>T (p.Ser2389=)
NM_206933.3:c.7167C>T
NC_000001.11:g.215934749G>A
CM000663.2:g.215934749G>A
NC_000001.10:g.216108091G>A
CM000663.1:g.216108091G>A
NC_000001.9:g.214174714G>A
NG_009497.1:g.493648C>T
NG_009497.2:g.493700C>T
NM_206933.2:c.7167C>T
NM_206933.4:c.7167C>T
ENST00000307340.7:c.7167C>T
More

Likely Benign

Met criteria codes 3
BP7 BP4 BS1_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The filtering allele frequency (the lower threshold of the 95% CI of 57/19928 of the c.7167C>T (p.Ser2389=) variant in the USH2A gene is 0.22% for East Asian chromosomes by gnomAD v2.1.1, which is a higher frequency than would be expected for an autosomal recessive pathogenic variant based on the thresholds defined by the ClinGen Hearing Loss Expert Panel (BS1_Supporting). The silent c.7167C>T variant in USH2A is not predicted by the computational prediction analysis using MaxEntScan to impact splicing (BP4, BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1_P, BP4,BP7.
Met criteria codes
BP7
no splicing impact predicted by MaxEntScan and other splicing predictors in Alamut.
BP4
Residue is not highly conserved and no splicing impact predicted by MaxEntScan and other splicing predictors in Alamut.
BS1_Supporting
The filtering AF (95% CI) is 0.22% (57/19928) of East Asian chromosomes in gnomAD v2.1.1 and 0.22% (12/3114) of South Asian chromosomes in gnomAD v3.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.